ATOSSA THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q3 2011 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Atossa Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2011 to Q2 2024.
Atossa Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$7.11M, a 8.83% increase year-over-year.
Atossa Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$30.6M, a 2.14% increase year-over-year.
Atossa Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$31.4M, a 13.3% decline from 2022.
Atossa Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$27.7M, a 34.9% decline from 2021.
Atossa Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$20.5M, a 40.5% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$30.6M	-$7.11M	+$688K	+8.83%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	-$31.3M	-$6.98M	+$118K	+1.66%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	-$31.4M	-$9.02M	-$874K	-10.7%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-01
Q3 2023	-$30.5M	-$7.47M	+$737K	+8.98%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	-$31.2M	-$7.79M	-$1.2M	-18.2%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-12
Q1 2023	-$30M	-$7.1M	-$2.35M	-49.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q4 2022	-$27.7M	-$8.14M	-$3.32M	-68.7%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-01
Q3 2022	-$24.4M	-$8.21M	-$3.05M	-59.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$21.3M	-$6.6M	+$409K	+5.84%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	-$21.7M	-$4.75M	-$1.22M	-34.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$20.5M	-$4.83M	-$603K	-14.3%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-22
Q3 2021	-$19.9M	-$5.16M	-$1.65M	-47%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-07
Q2 2021	-$18.3M	-$7M	-$3.07M	-78%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	-$15.2M	-$3.53M	-$594K	-20.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-09
Q4 2020	-$14.6M	-$4.23M	-$1.61M	-61.5%	Oct 1, 2020	Dec 31, 2020	10-K	2022-02-28
Q3 2020	-$13M	-$3.51M	-$211K	-6.39%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$12.8M	-$3.94M	+$3.35M	+46%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-13
Q1 2020	-$16.1M	-$2.94M	+$1.13M	+27.7%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	-$17.3M	-$2.62M	-$510K	-24.2%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-31
Q3 2019	-$16.8M	-$3.3M	+$11.8K	+0.36%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-13
Q2 2019	-$16.8M	-$7.29M	-$3.14M	-75.9%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$13.6M	-$4.06M	-$2.19M	-117%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-13
Q4 2018	-$11.4M	-$2.11M	-$114K	-5.71%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-26
Q3 2018	-$11.3M	-$3.31M	-$1.25M	-61%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-13
Q2 2018	-$10.1M	-$4.14M	-$2.25M	-118%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	-$7.82M	-$1.87M	-$171K	-10%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-13
Q4 2017	-$7.65M	-$1.99M	+$367K	+15.5%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-28
Q3 2017	-$8.02M	-$2.06M	-$497K	-31.9%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$7.52M	-$1.9M	-$174K	-10.1%	Apr 1, 2017	Jun 30, 2017	10-Q/A	2018-11-13
Q1 2017	-$7.34M	-$1.7M	+$624K	+26.8%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-14
Q4 2016	-$7.97M	-$2.36M	+$113K	+4.55%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-08
Q3 2016	-$8.08M	-$1.56M	+$2.28M	+59.4%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-13
Q2 2016	-$10.4M	-$1.72M	+$1.45M	+45.7%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	-$11.8M	-$2.33M	+$945K	+28.9%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-11
Q4 2015	-$12.8M	-$2.47M	+$856K	+25.7%	Oct 1, 2015	Dec 31, 2015	10-K/A	2017-03-21
Q3 2015	-$13.6M	-$3.84M	-$597K	-18.4%	Jul 1, 2015	Sep 30, 2015	10-Q/A	2017-03-21
Q2 2015	-$13M	-$3.17M	+$16K	+0.5%	Apr 1, 2015	Jun 30, 2015	10-Q/A	2017-03-21
Q1 2015	-$13M	-$3.27M	-$862K	-35.7%	Jan 1, 2015	Mar 31, 2015	10-Q/A	2017-03-21
Q4 2014	-$12.2M	-$3.33M	-$570K	-20.7%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-30
Q3 2014	-$11.6M	-$3.25M	+$257K	+7.33%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-12
Q2 2014	-$11.9M	-$3.19M	-$603K	-23.3%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-06
Q1 2014	-$11.3M	-$2.41M	-$469K	-24.2%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-13
Q4 2013	-$10.8M	-$2.76M	-$1.05M	-61.7%	Oct 1, 2013	Dec 31, 2013	10-K	2015-03-30
Q3 2013	-$9.73M	-$3.5M	-$2.37M	-208%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-12
Q2 2013	-$7.37M	-$2.58M	-$1.42M	-122%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-12
Q1 2013	-$5.95M	-$1.94M	-$879K	-82.8%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-14
Q4 2012	-$5.07M	-$1.71M			Oct 1, 2012	Dec 31, 2012	10-K	2014-03-27
Q3 2012		-$1.14M	+$139K	+10.9%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-12
Q2 2012		-$1.17M			Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-14
Q1 2012		-$1.06M			Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-15
Q3 2011		-$1.27M			Jul 1, 2011	Sep 30, 2011	10-Q/A	2013-01-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.